Publications, Presentations, & Abstracts

LIFE-THREATENING MALIGNANCY IN PREGNANCY: A CASE SERIES OF THREE PATIENTS TREATED WITH PROTON RADIOTHERAPY WITH LONG TERM FOLLOW-UP

G Kurtz, A Kalbasi, B Hartl, B Bieda, U Amit, M Alonso-Basanta, ...

Radiotherapy and Oncology 210, S42

2025

Clinical Evaluation of AI-Generated Contours for Pediatric Proton CSI: A Blinded Expert Review

A Choi, GD Kao, CE Hill-Kayser, HG Hubbeling, ES Lebow, S Ramesh, ...

International Journal of Radiation Oncology, Biology, Physics 123 (1), e19

2025

MR vs CT-Based Cardiac Delineation in Pediatric Patients with Hodgkin Lymphoma

S Ramesh, Y Gao, B Li, JR Rocchetti, CE Hill-Kayser, G Kurtz, ...

International Journal of Radiation Oncology, Biology, Physics 123 (1), e204-e205

2025

Outcomes of Radiation Therapy Integrated with T-cell Engaging Bispecific Antibodies in Relapsed/Refractory Multiple Myeloma

H Patel, H Hubbeling, K Yu, M Carpenter, M LaRiviere, A Cohen, S Kapur, ...

Clinical Lymphoma Myeloma and Leukemia 25, S99

2025

Bridging radiotherapy before chimeric antigen receptor T cells for B-cell lymphomas: an ILROG multicenter study

N Yegya-Raman, JP Plastaras, CM Wright, M Chelius, S Zhang, JA Baron, ...

Blood Advances 9 (13), 3293-3303

3

2025

PEMBROLIZUMAB AND RADIATION THERAPY ALONE AS AN ALTERNATIVE TO TRANSPLANT FOR LOCALIZED FAILURE AFTER CHEMOTHERAPY IN HODGKIN LYMPHOMA: A MULTICENTER PHASE II STUDY

AD Dreyfuss, N Ganesan, BS Imber, M LaRiviere, D Isrow, J Plastaras, ...

Hematological Oncology 43, e129_70093

2025

Pembrolizumab in Relapsed or Refractory Mycosis Fungoides or Sézary Syndrome

O Elghawy, JH Sussman, AG Yang, CJ Thomas, JS Carter, DJ Landsburg, ...

JAMA dermatology 161 (6), 656-658

1

2025

Assessment of generic corrections for multiview Cherenkov emission during total skin electron therapy (TSET)

Y Zhu, B Lu, B Byrd, L Chen, E Xiong, JP Plastaras, M LaRiviere, ...

Optical Methods for Tumor Treatment and Detection: Mechanisms and Techniques …

2025

Mental Health Diagnoses in Patients With Mycosis Fungoides and Potential Impact on Oncologic Outcomes

JN Howell, B Mark, DA Wada, M Bowling, M Wei, SL Lloyd, DK Gaffney, ...

Cancer Medicine 14 (5), e70577

1

2025

Patterns and disparities of proton therapy utilization among adult cancer patients

C Hollawell, S Zhang, AG Santos, E MacDuffie, C Friedes, R Eisenberg, ...

International Journal of Particle Therapy 15, 100680

2025

Retrospective cohort study of novel oral agents lenalidomide and duvelisib for relapsed or refractory mycosis fungoides and Sézary syndrome

O Elghawy, AG Yang, JH Sussman, CJ Thomas, JS Carter, DJ Landsburg, ...

Journal of the American Academy of Dermatology 92 (3), 634-636

2025

Local radiation enhances systemic CAR T-cell efficacy by augmenting antigen crosspresentation and T-cell infiltration

N Kostopoulos, F Costabile, E Krimitza, S Beghi, D Goia, ...

Blood Advances 8 (24), 6308-6320

10

2024

Outcomes of proton therapy to infradiaphragmatic sites in pediatric patients with Hodgkin lymphoma

C Jiang, M Kim, X Han, M Chelius, T Hoover, L Kersun, AF Reilly, ...

Pediatric Blood & Cancer 71 (12), e31290

3

2024

Pembrolizumab and Involved Site Radiation Therapy Alone As an Alternative to Transplant in Patients with Localized Failure Following Chemotherapy for Hodgkin Lymphoma: A …

A Dreyfuss, N Ganesan, AJ Alencar, AP Boardman, P Caron, T Chang, ...

Blood 144 (Supplement 1), 4434-4434

2024

Real-World Outcomes of Early Relapsed/Refractory Large B Cell Lymphoma Patients Treated with 2nd Line CAR T Therapy

M Schneider, EA Chong, SK Barta, SD Nasta, J Svoboda, J Carter, ...

Blood 144, 5123

1

2024

BIOM-43. SOMATICTP53, PIK3R1, NF1 ORTERT MUTATIONS ARE ASSOCIATED WITH INFERIOR CLINICAL OUTCOME IN H3K27M-ALTERED DIFFUSE …

T Nguyen, B Lerman, S Stoller, T Müller, L Comfort, S Leal-Ekman, ...

Neuro-Oncology 26 (Supplement_8), viii29-viii29

2024

Mental Health in Mycosis Fungoides Patients and Its Impact on Survival Outcomes

J Howell, B Mark, D Wada, M Bowling, A Maity, D Gaffney, S Lloyd, ...

AMERICAN JOURNAL OF CLINICAL ONCOLOGY-CANCER CLINICAL TRIALS 47 (10), S25-S26

2024

Initial Clinical Experience of Cherenkov Imaging in Sub-Total Total Skin Electron Therapy Identifies Opportunities to Improve Daily Set-Up QA

B Byrd, Y Zhu, DA Alexander, M Chelius, GM Freedman, MJ LaRiviere, ...

International Journal of Radiation Oncology, Biology, Physics 120 (2), S20

2024

The Impact of Standard vs. Hypofractionated Total Skin Electron Beam Therapy (TSE) on Cytopenias in Mycosis Fungoides/Sezary Syndrome (MF/SS)

M Chelius, L Cohen, C Jiang, J Baron, J Mallon, A Tierney, HG Hubbeling, ...

International Journal of Radiation Oncology, Biology, Physics 120 (2), e614

2024

Radiation in Combination with Bispecific Therapy Does Not Suggest Excess Toxicity in B-Cell Lymphomas

M Chelius, J Baron, N Yegya-Raman, E Chong, SD Nasta, DJ Landsburg, ...

International Journal of Radiation Oncology, Biology, Physics 120 (2), e614-e615

2024

Income Inequality in Patients (Pts) with Locally Advanced (LA) Non-Small Cell Lung Cancer (NSCLC) Receiving Proton BeamTherapy

XAA Konski, M Iocolano, N Yegya-Raman, R Cohen, C Langer, C Friedes, ...

International Journal of Radiation Oncology, Biology, Physics 120 (2), e35

2024

52332 Safety of Total Skin Electron Therapy with Concurrent Systemic Therapy

M Chelius, L Cohen, J Mallon, A Rook, J Villasenor-Park, S Samimi, ...

Journal of the American Academy of Dermatology 91 (3), AB308

2024

TCL-320 Single Institution Experience of Pembrolizumab for Patients with Relapsed or Refractory Mycosis Fungoides or Sézary Syndrome

O Elghawy, CJ Thomas, JS Carter, DJ Landsburg, J Svoboda, E Kim, ...

Clinical Lymphoma Myeloma and Leukemia 24, S522

2024

Single Institution Experience of Pembrolizumab for Patients with Relapsed or Refractory Mycosis Fungoides or Sézary Syndrome

O Elghawy, J Sussman, A Yang, CJ Thomas, JS Carter, DJ Landsburg, ...

Steroids 5, 16.7

2024

Radiation Therapy Dose Response in Bulky Relapsed/Refractory Large B-Cell Lymphoma

JA Baron, CM Wright, AD Dreyfuss, EA Chong, J Svoboda, MJ LaRiviere, ...

Practical Radiation Oncology 14 (5), e362-e372

1

2024

A Review of Follicular Lymphoma in 4 Cases

A Matous, L Jarvis, M LaRiviere

2024

Can Simple Analytical Algorithm Predict Dose Distribution for Total Skin Electron Therapy (TSET)?

TC Zhu, Y Zhu, BK Byrd, B Lu, DA Alexander, M LaRiviere, J Plastaras

AAPM 66th Annual Meeting & Exhibition

2024

DIPG-77. SOMATICTP53, PIK3R1, NF1 ORTERT MUTATIONS ARE ASSOCIATED WITH INFERIOR CLINICAL OUTCOME IN H3K27M-ALTERED DIFFUSE MIDLINE GLIOMA

T Nguyen, B Lerman, S Stoller, T Müller, L Comfort, S Lyons, L Holman, ...

Neuro-Oncology 26 (Suppl 4), 0

2024

Safety and efficacy of armored huCART19-IL18 in patients with relapsed/refractory lymphomas that progressed after anti-CD19 CAR T cells.

J Svoboda, DJ Landsburg, SD Nasta, SK Barta, EA Chong, MJ Lariviere, ...

Journal of Clinical Oncology 42 (16_suppl), 7004-7004

13

2024

A Prospective Phase I/II Clinical Trial of High-Dose Proton Therapy for Chordomas and Chondrosarcomas

SS Dastgheyb, AD Dreyfuss, MJ LaRiviere, JJ Mohiuddin, BC Baumann, ...

Advances in radiation oncology 9 (5), 101456

9

2024

Validation of the Cherenkov converted dose using multiple Cherenkov images on TSET patients

Y Zhu, B Byrd, D Alexander, A Maity, JP Plastaras, M LaRiviere, ...

Optical Methods for Tumor Treatment and Detection: Mechanisms and Techniques …

2024

Delivery of re-irradiation and complex palliative radiotherapy using proton therapy in pediatric cancer patients

E Berlin, R Eisenberg, C Hill-Kayser, RA Lustig, G Kurtz, E Cummings, ...

International Journal of Particle Therapy 11, 100035

2024

Outcomes of proton therapy for patients with infradiaphragmatic lymphoma

C Jiang, T Hoover, M Kim, X Han, J Plastaras, M LaRiviere

International Journal of Particle Therapy 11, 100033

2024

Delivery of re‐irradiation and complex palliative radiotherapy using proton therapy in pediatric cancer patients

E Berlin, R Eisenberg, C Hill‐Kayser, RA Lustig, G Kurtz, E Cummings, ...

Pediatric Blood & Cancer 70 (12), e30708

2

2023

Safety of Total Skin Electron Therapy with Concurrent Systemic Therapy

M Chelius, L Cohen, C Jiang, J Mallon, J Greisz, A Tierney, N Hossain, ...

Blood 142, 6182

1

2023

Outcomes of Proton Therapy to Infradiaphragmatic Sites in Pediatric Hodgkin Lymphoma Patients

C Jiang, M Kim, M Chelius, X Han, T Hoover, L Kersun, AF Reilly, ...

Blood 142, 6185

2023

Outcomes of Proton Therapy for Patients with Infradiaphragmatic Lymphoma

C Jiang, T Hoover, MM Kim, X Han, JP Plastaras, MJ LaRiviere

International Journal of Radiation Oncology, Biology, Physics 117 (2), e470

2023

Survival and Local Recurrence Risk in Patients with High-Risk Neuroblastoma Treated with Proton Therapy over a 10 Year Interval

CE Hill-Kayser, Y Li, G Kurtz, P Mattei, F Balis, RA Lustig, MJ LaRiviere, ...

International Journal of Radiation Oncology, Biology, Physics 117 (2), e516-e517

2023

Bridging Radiotherapy Prior to Chimeric Antigen Receptor T-Cell Therapy for B-Cell Lymphomas: An ILROG Multi-Institutional Study

N Yegya-Raman, CM Wright, CJ Ladbury, J Chew, S Zhang, SY Sun, ...

International Journal of Radiation Oncology, Biology, Physics 117 (2), S50-S51

3

2023

Early-Stage Primary Lung Neuroendocrine Tumors Treated With Stereotactic Body Radiation Therapy: A Multi-Institution Experience

DE Oliver, JM Laborde, DP Singh, MT Milano, GM Videtic, GR Williams, ...

International Journal of Radiation Oncology* Biology* Physics 116 (4), 849-857

3

2023

Liquid biopsy signature combining copy number instability and mutant KRAS detection is associated with survival for patients with metastatic pancreatic cancer

S Cannas, JE Till, K Kim, MJ LaRiviere, CM Vollmer, JR Eads, TB Karasic, ...

Cancer Research 83 (7_Supplement), 1043-1043

2023

Severe acute radiation dermatitis after palbociclib therapy in the setting of palliative radiotherapy

KN Kim, M Salerno, PD Shah, J Matro, MJ LaRiviere

Journal of Oncology Pharmacy Practice 29 (3), 764-767

1

2023

Evaluation of the cumulative Cherenkov converted dose on TSET patients with multiple Cherenkov cameras

Y Zhu, DA Alexander, T Miao, A Maity, JP Plastaras, I Paydar, M LaRiviere, ...

Optical Methods for Tumor Treatment and Detection: Mechanisms and Techniques …

3

2023

Salvage radiotherapy for relapsed/refractory non‐Hodgkin lymphoma following CD19 chimeric antigen receptor T-cell (CART) therapy

N Yegya-Raman, CM Wright, MJ LaRiviere, JA Baron, DY Lee, ...

Clinical and Translational Radiation Oncology 39, 100587

5

2023

Life-threatening altered mental status secondary to memantine in an adolescent undergoing cranial radiotherapy for medulloblastoma

KN Kim, YB Shah, C Croy, RA Lustig, M LaRiviere, C Kotch

Journal of Oncology Pharmacy Practice 29 (2), 469-472

3

2023

Proton Radiation Therapy After Chemotherapy in the Management of Aggressive Mediastinal Non-Hodgkin Lymphomas: A Particle Therapy Cooperative Group Lymphoma Subcommittee …

JA Baron, CM Wright, R Maxwell, MM Kim, F Giap, RBM Vega, BS Hoppe, ...

Advances in Radiation Oncology 8 (1), 101090

2

2023

Use of Glucocorticoids in Patients With Cancer: Potential Benefits, Harms, and Practical Considerations for Clinical Practice

KN Kim, M LaRiviere, E Macduffie, CA White, MM Jordan-Luft, ...

Practical Radiation Oncology 13 (1), 28-40

13

2023

Design and implementation of an Internet‐Based cancer risk assessment tool: Use over 10 years

MJ LaRiviere, R O'Keefe, M Carpenter, HH Chao, I Amaniera, C Vachani, ...

Cancer Medicine 12 (2), 1744-1761

2023

Multi-Institutional Review of Bridging Radiotherapy Prior to Chimeric Antigen Receptor T-Cell Therapy for B-Cell Lymphomas

N Yegya-Raman, CM Wright, NB Figura, S Zhang, JJ Chew, SE Burke, ...

Blood 140 (Supplement 1), 10900-10901

1

2022

Low-Dose Radiation Therapy with Nivolumab in Patients with Relapsed/Refractory Hodgkin Lymphoma: Results of the Phase II Radvax Trial

MJ LaRiviere, T Vaziri, M Farwell, A Maity, I Paydar, SJ Schuster, ...

Blood 140 (Supplement 1), 3726-3727

3

2022

Conformal Pencil Beam Scanning Proton Therapy for Delivery of Flank Radiation in Children with Renal Tumors

CE Hill-Kayser, J Vogel, Y Li, RA Lustig, G Kurtz, MJ LaRiviere, ...

International Journal of Radiation Oncology, Biology, Physics 114 (3), S71-S72

2022

Dose Response of Bulky Tumors in Relapsed/Refractory Diffuse Large B-Cell Lymphoma

RJL Maxwell, CM Wright, J Baron, A Dreyfuss, MJ LaRiviere, EA Chong, ...

International Journal of Radiation Oncology, Biology, Physics 114 (3), S134-S135

2022

Radiation Therapy for Bridging and Improving CAR-T Cell Therapy

N Kostopoulos, S Bedgi, E Krimitza, F Costabile, I Paydar, MM Kim, ...

International Journal of Radiation Oncology, Biology, Physics 114 (3), S83-S84

3

2022

Cytokine Release Syndrome and Neurotoxicity after Chimeric Antigen Receptor T-Cell Therapy for Relapsed/Refractory B-Cell Lymphoma: Is There an Association with Bridging …

N Yegya-Raman, CM Wright, S Zhang, J Baron, MJ LaRiviere, JN Gerson, ...

International Journal of Radiation Oncology, Biology, Physics 114 (3), S84-S85

2

2022

Pencil Beam Scanning (PBS) Proton Therapy for Children Requiring Radiotherapy with Anesthesia (GA) for Pelvic Rhabdomyosarcoma (RMS)

MJ LaRiviere, P James, K Clegg, ER Cummings, R Bagatell, N Balamuth, ...

International Journal of Radiation Oncology, Biology, Physics 114 (3), e489-e490

1

2022

Association Between Radiation Exposure and Family History of Cancer: Analysis of an Online Risk Assessment Tool

YB Shah, M Rose, C Vachani, JM Metz, CE Hill-Kayser, MJ LaRiviere

International Journal of Radiation Oncology, Biology, Physics 114 (3), e423-e424

2022

A Phase I/II Clinical Trial of Proton Therapy for Chordomas and Chondrosarcomas

SS Dastgheyb, A Dreyfuss, MJ LaRiviere, JJ Mohiuddin, BC Baumann, ...

International Journal of Radiation Oncology, Biology, Physics 114 (3), S167

2022

High-grade Acute Radiation Dermatitis in the Setting of Palliative Radiotherapy After Palbociclib Therapy

K Kim, P Shah, M Salerno, M LaRiviere

AMERICAN JOURNAL OF CLINICAL ONCOLOGY-CANCER CLINICAL TRIALS 45 (9), S52-S53

2022

Outcomes Following Combined Radiotherapy with Brentuximab Vedotin or PD-1 Inhibitors in Relapsed/refractory Classical Hodgkin Lymphoma

J Plastaras, R Maxwell, S Man-Junath, M Twerski, M Carpenter, ...

AMERICAN JOURNAL OF CLINICAL ONCOLOGY-CANCER CLINICAL TRIALS 45 (9), S14-S14

2022

Association Between Family History and Other Risk Factors for Urologic Malignancies: Analysis of an Online Risk Assessment Tool

Y Shah, M Rose, C Vachani, J Metz, C Hill-Kayser, M LaRiviere

AMERICAN JOURNAL OF CLINICAL ONCOLOGY-CANCER CLINICAL TRIALS 45 (9), S31-S31

2022

Association Between Family History and Established Risk Factors for Male Reproductive Cancers: Analysis of a Personalized Cancer Risk Assessment Tool

M Rose, Y Shah, C Vachani, J Metz, C Hill-Kayser, M LaRiviere

AMERICAN JOURNAL OF CLINICAL ONCOLOGY-CANCER CLINICAL TRIALS 45 (9), S63-S63

2022

Halcyon-Based Lung-Sparing Total Body Irradiation Therapy: A Feasibility Study

A Haertter, M LaRiviere, T Li, M Kim

AMERICAN JOURNAL OF CLINICAL ONCOLOGY-CANCER CLINICAL TRIALS 45 (9), S40-S41

2022

Evaluation of Consolidative Proton Radiotherapy Following Chemotherapy in the Treatment of Aggressive Mediastinal Non-Hodgkin Lymphomas

J Baron, C Wright, R Maxwell, M Kim, F Giap, RM Vega, B Hoppe, ...

AMERICAN JOURNAL OF CLINICAL ONCOLOGY-CANCER CLINICAL TRIALS 45 (9), S13-S13

2022

Life-threatening Altered Mental Status Secondary to Memantine in a Patient Undergoing Palliative Cranial Radiotherapy for Medulloblastoma

K Kim, Y Shah, C Croy, R Lustig, M LaRiviere, C Kotch

AMERICAN JOURNAL OF CLINICAL ONCOLOGY-CANCER CLINICAL TRIALS 45 (9), S41-S42

2022

Multianalyte Prognostic Signature Including Circulating Tumor DNA and Circulating Tumor Cells in Patients With Advanced Pancreatic Adenocarcinoma

WJ Chapin, JE Till, WT Hwang, JR Eads, TB Karasic, PJ O'Dwyer, ...

JCO Precision Oncology 6, e2200060

12

2022

General Anesthesia for Pediatric Radiation Therapy in the Era of COVID-19

MJ LaRiviere, YB Shah, ER Cummings, K Clegg, A Doucette, BP Struyk, ...

Advances in radiation oncology 7 (4), 100929

2

2022

MYC levels regulate metastatic heterogeneity in pancreatic adenocarcinoma

R Maddipati, RJ Norgard, T Baslan, KS Rathi, A Zhang, A Saeid, ...

Cancer discovery 12 (2), 542-561

98

2022

Correction: THBS2 as a prognostic biomarker for patients diagnosed with metastatic pancreatic ductal adenocarcinoma

PA Gimotty, JE Till, S Udgata, N Takenaka, SS Yee, MJ LaRiviere, ...

Oncotarget 13, 1187

2022

Applications of a CT-compatible 3D Printed Plastic Scrotal “Clamshell” for Radiotherapy Planning, Proton Beam Shielding, and Testicular Immobilization

SE Burke, A Kassaee, JP Plastaras, A Gray, CE Hill-Kayser, X Ding, ...

Journals of Case Reports in Medicine 11 (4)

2022

Applications of a 3D Printed Plastic Scrotal" clam-shell" for CT-compatible Radiotherapy Planning, Proton Beam Shielding, and Testicular Immobilization

S Burke, A Kassaee, J Plastaras, A Gray, C Hill-Kayser, X Ding, N Thorne, ...

2022

Salvage Radiotherapy for Relapsed/Refractory Non‐Hodgkin Lymphomas Following CD19 Chimeric Antigen Receptor T-Cell (CART) Therapy

CM Wright, N Yegya-Raman, J Baron, DY Lee, EA Chong, MJ LaRiviere, ...

International Journal of Radiation Oncology, Biology, Physics 111 (3), S132-S133

2

2021

Contribution of Family History of Head and Neck Cancer and Associated Risk Factors: Analysis of an Internet Based Risk Assessment Tool

R O'Keefe, MJ LaRiviere, C Vachani, MK Hampshire, C Bach, ...

International Journal of Radiation Oncology* Biology* Physics 111 (3), e376

2021

THSB2 as a prognostic biomarker for patients diagnosed with metastatic pancreatic ductal adenocarcinoma

PA Gimotty, JE Till, S Udgata, N Takenaka, SS Yee, MJ LaRiviere, ...

Oncotarget 12 (22), 2266-2272

5

2021

Design and Implementation of an Internet-Based Cancer Risk Assessment Tool: Use over 10 Years

M LaRiviere, R O'Keefe, M Carpenter, HH Chao, I Amaniera, C Vachani, ...

AMERICAN JOURNAL OF CLINICAL ONCOLOGY-CANCER CLINICAL TRIALS 44 (10), S96-S98

2021

LYMPHOMA, MYELOMA LEUKEMIA

P Bose, S Verstovsek, CM Wright, AI Koroulakis, JA Baron, EA Chong, ...

2021

Impact of Socioeconomic Status on Cervical Cancer Prevention and Screening

C Hill-Kayser, R Dave, M LaRiviere, C Vachani, M Hampshire, J Metz, ...

AMERICAN JOURNAL OF CLINICAL ONCOLOGY-CANCER CLINICAL TRIALS 44 (10), S93-S94

2021

Palliative radiotherapy for diffuse large B-cell lymphoma

CM Wright, AI Koroulakis, JA Baron, EA Chong, YD Tseng, G Kurtz, ...

Clinical Lymphoma Myeloma and Leukemia 21 (10), 650-658

14

2021

Proton reirradiation for locoregionally recurrent breast cancer

MJ LaRiviere, A Dreyfuss, NK Taunk, GM Freedman

Advances in Radiation Oncology 6 (4), 100710

20

2021

Contribution of family history of melanoma to associated risk factors: Analysis of an Internet-based risk assessment tool.

RM O'Keefe, MJ LaRiviere, C Vachani, MK Hampshire, C Bach, ...

Journal of Clinical Oncology 39 (15_suppl), 10546-10546

2021

Combining radiomic phenotypes of non-small cell lung cancer with liquid biopsy data may improve prediction of response to EGFR inhibitors

B Yousefi, MJ LaRiviere, EA Cohen, TH Buckingham, SS Yee, TA Black, ...

Scientific reports 11 (1), 9984

31

2021

FP09. 04 Association Between Family History and Other Risk Factors for Lung Cancer: Analysis of an Internet-Based Risk Assessment

R O'Keefe, M Lariviere, C Vachani, M Hampshire, C Bach, ...

Journal of Thoracic Oncology 16 (3), S213-S214

2021

Abstract PS7-80: Family history (FH) of breast cancer (BC) and associated risk-factors and screening: Analysis of an internet-based risk assessment tool

R O'Keefe, M LaRiviere, C Vachani, M Hampshire, C Bach, ...

Cancer Research 81 (4_Supplement), PS7-80-PS7-80

2021

MYC controls metastatic heterogeneity in pancreatic cancer

R Maddipati, RJ Norgard, T Baslan, KS Rathi, A Zhang, P Raman, ...

bioRxiv, 2021.01. 30.428641

3

2021

Abstract PO-053: MYC Influences metastatic heterogeneity in pancreatic cancer

R Maddipati, RJ Norgard, T Baslan, KS Rathi, A Zhang, P Raman, ...

Cancer Research 80 (22 Supplement), PO-053-PO-053

2020

Association Of Lymphoma Family History (FH) With Other Risk Factors For Cancer Development: Analysis Of An Internet-Based Risk Assessment Tool

R O'Keefe, MJ LaRiviere, C Vachani, MK Hampshire, C Bach, ...

International Journal of Radiation Oncology, Biology, Physics 108 (3), e760-e761

2020

Factors Associated With Fatigue in Patients with Breast Cancer Undergoing External Beam Radiation Therapy

MJ LaRiviere, HH Chao, A Doucette, TP Kegelman, NK Taunk, ...

Practical Radiation Oncology 10 (6), 409-422

12

2020

Blood-based gene expression signature associated with metastatic castrate-resistant prostate cancer patient response to abiraterone plus prednisone or enzalutamide

NB Haas, MJ LaRiviere, TH Buckingham, Y Cherkas, K Calara-Nielsen, ...

Prostate Cancer and Prostatic Diseases, 1-9

3

2020

Factors associated with fatigue in breast cancer patients undergoing external beam radiation therapy

M LaRiviere, HH Chao, A Doucette, T Kegelman, N Taunk, G Freedman, ...

International Journal of Radiation Oncology, Biology, Physics 108 (2), E16

1

2020

Impact of Radiotherapy on Hospitalization Burden Surrounding Chimeric Antigen Receptor T-Cell Therapy in Patients with Relapsed/Refractory Non-Hodgkin Lymphoma

C Wright, E Anstadt, J Baron, M LaRiviere, M LaRose, D Landsburg, ...

International Journal of Radiation Oncology* Biology* Physics 108 (2), E51-E52

2

2020

Bridging radiation therapy before commercial chimeric antigen receptor T-cell therapy for relapsed or refractory aggressive B-cell lymphoma

CM Wright, MJ LaRiviere, JA Baron, C Uche, Y Xiao, WT Arscott, ...

International Journal of Radiation Oncology* Biology* Physics 108 (1), 178-188

97

2020

A Multianalyte Panel Consisting of Extracellular Vesicle miRNAs and mRNAs, cfDNA, and CA19-9 Shows Utility for Diagnosis and Staging of Pancreatic Ductal Adenocarcinoma

Z Yang, MJ LaRiviere, J Ko, JE Till, T Christensen, SS Yee, TA Black, ...

Clinical Cancer Research 26 (13), 3248-3258

116

2020

Evaluation of PET/clinical Parameters to Predict Toxicity in Chimeric Antigen Receptor T-Cell Therapy Patients with Relapsed/refractory Non-Hodgkin Lymphoma

C Uche, C Wright, J Baron, M Lariviere, A Barsky, D Miller, A Maity, ...

MEDICAL PHYSICS 47 (6), E772-E773

2020

Contribution of family history of gynecologic cancers to associated risk-factors and screening: Analysis of an Internet-based risk assessment tool.

RM O'Keefe, MJ Lariviere, C Vachani, MK Hampshire, C Bach, ...

Journal of Clinical Oncology 38 (15_suppl), e13605-e13605

1

2020

Baseline Plasma Tumor Mutation Burden Predicts Response to Pembrolizumab-based Therapy in Patients with Metastatic Non–Small Cell Lung Cancer

C Aggarwal, JC Thompson, AL Chien, KJ Quinn, WT Hwang, TA Black, ...

Clinical Cancer Research 26 (10), 2354-2361

107

2020

CAR-T cell therapy for lymphoma: how does radiation therapy fit in?

AD Dreyfuss, M Lariviere, LK Ballas, JP Plastaras

Practical radiation oncology 10 (3), e155-e158

10

2020

Introducing Multidisciplinary Oncology Management to the Medical Student

MJ LaRiviere, PMG Santos, JA Jones, JN Lukens, N Vapiwala, ...

Advances in radiation oncology 5 (2), 289-291

10

2020

A Phase I/II Clinical Trial of Proton Therapy for Chordomas and Chondrosarcomas

AD Dreyfuss, MJ LaRiviere, JJ Mohiuddin, BC Baumann, DM Miller, ...

Journal of Neurological Surgery Part B: Skull Base 81 (S 01), A091

2020

Family history (FH) of gastrointestinal (GI) cancer and behavioral risks: Analysis of an Internet-based risk assessment tool.

RM O'Keefe, MJ Lariviere, I Amaniera, C Vachani, MK Hampshire, C Bach, ...

Journal of Clinical Oncology 38 (4_suppl), 807-807

2020

Proton Therapy

MJ LaRiviere, PMG Santos, CE Hill-Kayser, JM Metz

Hematology/Oncology Clinics 33 (6), 989-1009

71

2019

MA25. 04 Blood-Based Tumor Mutation Burden as a Predictive Biomarker for Outcomes After Pembrolizumab Based First Line Therapy in Metastatic NSCLC

C Aggarwal, J Thompson, A Chien, K Quinn, M Lefterova, R Nagy, S Yee, ...

Journal of Thoracic Oncology 14 (10), S352

6

2019

Induction Radiation Prior to Commercial Chimeric Antigen Receptor T-Cell Therapy for Relapsed/Refractory Non-Hodgkin Lymphoma

MJ LaRiviere, CM Wright, WT Arscott, D Miller, E Weber, DJ Landsburg, ...

International Journal of Radiation Oncology* Biology* Physics 105 (1), S66

10

2019

Emergent Radiation for Leukemic Optic Nerve Infiltration in a Child Receiving Intrathecal Methotrexate

MJ LaRiviere, RA Avery, JG Dolan, PC Adamson, DM Zarnow, Y Xie, ...

Practical radiation oncology 9 (4), 226-230

3

2019

Important Technical Considerations for Implementing the ASTRO/ASCO/AUA Prostate Cancer Hypofractionated Radiation Guideline

MJ LaRiviere, TC Zhu, JP Christodouleas

Practical radiation oncology 9 (4), 197-199

2

2019

An evaluation of implicit bias training in graduate medical education

U Khatri, A Zeidan, M LaRiviere, S Sanchez, L Weaver, J Lynn, F Shofer, ...

MedEdPublish 8, 109

11

2019

Design and implementation of outpatient-based rapid MRI protocols to rule out metastatic spinal cord compression and brain metastases.

JG Fried, MJ Lariviere, RB Parikh, PZ Sullivan, GP Kanter, JYK Lee, ...

Journal of Clinical Oncology 37 (15_suppl), e18307-e18307

2019

Prediction of metastatic castrate-resistant prostate cancer response to abiraterone or enzalutamide by a baseline blood-based CTC gene expression signature.

MJ Lariviere, NB Haas, Y Cherkas, K Nielsen, B Foulk, J Patel, D Smirnov, ...

Journal of Clinical Oncology 37 (15_suppl), e16529-e16529

1

2019

Design and implementation of an Internet-based cancer risk assessment tool: Use over 10 years.

MJ Lariviere, HH Chao, I Amaniera, C Vachani, MK Hampshire, C Bach, ...

Journal of Clinical Oncology 37 (15_suppl), e13075-e13075

1

2019

Acute and Late Toxicity of Hyperfractionated Reirradiation for Locoregionally Recurrent Breast Cancer

MJ LaRiviere, A Dreyfuss, NK Taunk, GM Freedman

International Journal of Radiation Oncology• Biology• Physics 103 (5), E25-E26

1

2019

Educational Opportunities in Radiation Oncology for the Non-Radiation Oncologist

MJ LaRiviere, SD Swisher-McClure, N Vapiwala, AT Berman

International Journal of Radiation Oncology• Biology• Physics 103 (5), 1287-1288

2

2019

Correlative hierarchical clustering-based low-rank dimensionality reduction of radiomics-driven phenotype in non-small cell lung cancer

B Yousefi, N Jahani, MJ LaRiviere, E Cohen, MK Hsieh, JM Luna, ...

Medical Imaging 2019: Imaging Informatics for Healthcare, Research, and …

10

2019

Immune Therapies for Lymphomas: A Disruptive Technology With Opportunities for Radiation

MJ LaRiviere, CC Pinnix, JP Plastaras

International Journal of Radiation Oncology• Biology• Physics 102 (5), 1396-1399

1

2018

Clinically Significant Organ-at-risk Dose Reductions Are Achieved with IMRT Plan Optimization to Clinical Target Volume (CTV) with Setup Uncertainty Analysis

MJ LaRiviere, SE O'Reilly, AF Ghiam, SD Swisher-McClure, A Lin, ...

International Journal of Radiation Oncology• Biology• Physics 102 (3), e529

2018

(P04) High Volume of Low Dose Radiation Delivered to the Left Anterior Descending (LAD) Artery May Increase Risk for Coronary Artery Stenosis in Left-Sided Breast Cancer

CA Schonewolf, J Vogel, M LaRiviere, NK Taunk, JD Kolker, SN Nagda, ...

International Journal of Radiation Oncology* Biology* Physics 101 (2), E22

2018

Neuro-Oncology Pathway: Brain Metastasis

M LaRiviere, S Brem, A Rich, A Berman

Penn Pathways

2018

Mean Heart Dose and Distribution of Coronary Artery Stenosis in Breast Cancer Patients Treated With CT-Based Radiation Therapy

CA Schonewolf, J Vogel, MJ LaRiviere, JD Kolker, S Nagda, B Ky, ...

International Journal of Radiation Oncology• Biology• Physics 99 (2), E45-E46

2017

Metastatic Spinal Cord Compression (MSCC)

M LaRiviere, P Zadnik Sullivan, A Berman

Penn Pathways

2017

Breast Cancer Patients With Collagen Vascular Disease May Be Undertreated With Radiation Despite Low Rates of Toxicity

MJ LaRiviere, J Vogel, P Gabriel, GM Freedman

International Journal of Radiation Oncology* Biology* Physics 98 (2), E18

2017

Stereotactic Laser Ablation for Medically Intractable Epilepsy: The Next Generation of Minimally Invasive Epilepsy Surgery. Front Surg. 2016 Dec 5; 3: 64

MJ LaRiviere, RE Gross

11

2016

Stereotactic Laser Ablation for Medically Intractable Epilepsy: The Next Generation of Minimally Invasive Epilepsy Surgery

MJ LaRiviere, RE Gross

Frontiers in Surgery 3, 64

99

2016

Gene Therapy for Neuroprotection and Axon Regeneration Using a RhoA-Inhibitory C3 Transferase Transgene Adeno-Associated Viral Vector in a Rodent Optic Nerve Crush Model

MJ LaRiviere, ME McDougal, AW Wang, SL Syrop, R Robinson, ...

International Journal of Radiation Oncology* Biology* Physics 93 (3), E523-E524

2015

Hypofractionated radiosurgery has a better safety profile than single fraction radiosurgery for large resected brain metastases

BR Eaton, MJ LaRiviere, S Kim, RS Prabhu, K Patel, S Kandula, ...

Journal of Neuro-Oncology

99

2015

Genetic Syndromes: The Basics

MJ LaRiviere

OncoLink

2014

Computer simulations and in vivo convection-enhanced delivery of fluorescent nanoparticles demonstrate variable distribution geometry

E Lueshen, M LaRiviere, B Yamini, A Linninger

Computers & Chemical Engineering 71, 672-676

12

2014

Extraventricular Long-Axis Cannulation of the Hippocampus: Technical Considerations.

C Wu, MJ LaRiviere, N Laxpati, JJ Evans, RE Gross, AD Sharan

Neurosurgery

15

2014

Convection-enhanced delivery and in vivo imaging of polymeric nanoparticles for the treatment of malignant glioma

GM Bernal, MJ LaRiviere, N Mansour, P Pytel, KE Cahill, DJ Voce, ...

Nanomedicine: Nanotechnology, Biology and Medicine 10 (1), 149-157

119

2014

Anatomical dissociation of melanocortin receptor agonist effects on taste-and gut-sensitive feeding processes

JP Baird, M Palacios, M LaRiviere, LA Grigg, C Lim, E Matute, J Lord

American Journal of Physiology-Regulatory, Integrative and Comparative …

6

2011

Cerebrospinal fluid volume monitoring for hydrocephalus therapy

S Basati, M LaRiviere, R Penn, A Linninger

Journal of Medical Devices 5 (2), 027506

2011

Tumors of the Central Nervous System, Volume 1: Gliomas: Glioblastoma (Part 1)

MA Hayat

Springer Science & Business Media

11

2011

Malignant glioma: chemovirotherapy

SD Ferguson, MJ LaRiviere, N Mansour, MS Lesniak

Tumors of the Central Nervous System, Volume 1: Gliomas: Glioblastoma (Part …

1

2011

Convection enhanced delivery of biodegradable nanoparticles for the treatment of malignant glioma

MJ LaRiviere, N Mansour, N Galanopoulos, V Rawlani, K Prem, ...

Congress of Neurological Surgeons Annual Meeting

2

2010

Effects of melanotan II on gastric distension-responsive neurons of the nucleus of the solitary tract and on lick microstructure

MJ LaRiviere

Amherst College

2008

Development of Improved Treatment Options for Hydrocephalic Patients

S Basati, M LaRiviere, T Harris, R Penn, A Linninger